GRIPonMASH screens first patient and reports strong first-year results
Breaking milestones reached in project aiming to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH). Utrecht, The Netherlands, 17-12-2024: GRIPonMASH, a consortium dedicated to bring about a transformational change in the detection and diagnosis of MASH patients at different levels of health care management, completed its first year of research. GRIPonMASH focuses on designing […]
First patient successfully screened!
Reaching this milestone was a significant achievement and highlights the team’s incredible dedication and collaboration. We’re happy to announce that the first patient has been successfully screened under our consortiums protocol! This milestone was reached yesterday at Sint Franciscus Gasthuis & Vlietland in Rotterdam, under the guidance of Manuel Castro Cabezas. Reaching this milestone was […]
Preliminary results of GRIPonMASH presented at the Innovations in SLD Think-Tank 2024
On 3 and 4 May 2024 Vivian de Jong presented the GRIPonMASH project at the Innovations in SLD Think-Tank 2024 conference. Vivian de Jong, PhD Candidate, UMC Utrecht & Scientific officer, Julius Clinical, presented the GRIPonMASH project. The SLD Think-Tank conference focuses on bridging gaps and innovating solutions in the diagnosis, prevention, and treatment of […]
Successful Kick-off Meeting GRIPonMASH
Recap on the kick-off meeting in Seville (7 & 8 March) Last month, we convened the Kick-off Meeting in Seville. We commenced these days with introductions and outlined the project’s aims. Various partners delivered inspiring presentations, providing valuable insights. Moreover, it was a wonderful opportunity for everyone to meet face-to-face. Positive feedback attendees We had […]
GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)
New European project aims to improve tools and advice to prevent chronic liver illnesses. Utrecht, The Netherlands, 05-02-2024 GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Supported by the Innovative […]
